Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

1.06666

tri-Sodium citrate dihydrate low in endotoxins,

EMPROVE® API Ph Eur,BP,JP,USP

Synonym(s):

Sodium citrate tribasic dihydrate, Trisodium Citrate, Sodium Citrate, Dihydrate, Citric acid trisodium salt dihydrate, Trisodium citrate dihydrate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
1 kg
1 kg
25 kg

About This Item

Linear Formula:
HOC(COONa)(CH2COONa)2 · 2H2O
CAS Number:
6132-04-3
Molecular Weight:
294.10
EC Index Number:
200-675-3
UNSPSC Code:
12352302
Beilstein/REAXYS Number:
6104939
MDL number:
MFCD00150031

This item is not able to be purchased as a guest user. For further information, please contact us at +1 866 227 3811or

[email protected]
.

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

600

agency

BP, JP, Ph. Eur., USP

product line

EMPROVE® API

form

solid

potency

>8000 mg/kg LD50, oral (Rat)

pH

7.5-9.0 (25 °C, 50 g/L in H2O)

mp

150 °C (anhydrous substance), >300 °C (lit.)

solubility

720 g/L

bulk density

600 kg/m3

application(s)

liquid formulation
parenterals
pharma/biopharma processes
pharmaceutical
solid formulation

storage temp.

2-25°C

SMILES string

O.O.[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

InChI

1S/C6H8O7.3Na.2H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;2*1H2/q;3*+1;;/p-3

InChI key

NLJMYIDDQXHKNR-UHFFFAOYSA-K

General description

We provide industry-leading production know-how and comprehensive regulatory support for high-quality APIs, backed by nearly 200 years of experience. From a complete portfolio of innovative folates to custom synthesis, our customized and scalable solutions meet your specific production needs. As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

tri-Sodium citrate dihydrate is used as anticoagulant in dialysis and plasmapheresis. tri-Sodium citrate dihydrate Emprove® API is manufactured according to ICH Q7 guidelines. An ASMF and US-DMF is available.

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
1.064471.06432PHR1416
tri-Sodium citrate dihydrate low in endotoxins, EMPROVE® API Ph Eur,BP,JP,USP

SAFC

1.06666

tri-Sodium citrate dihydrate low in endotoxins,

tri-Sodium citrate dihydrate EMPROVE® EXPERT, Ph. Eur., BP, ChP, JP, USP, ACS, E 331

SAFC

1.06447

tri-Sodium citrate dihydrate

tri-Sodium citrate dihydrate crystalline, EMPROVE® ESSENTIAL, Ph. Eur., BP, JP, USP, E 331

SAFC

1.06432

tri-Sodium citrate dihydrate

Sodium Citrate Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1416

Sodium Citrate

form

solid

form

solid

form

crystalline, solid

form

-

application(s)

liquid formulation
parenterals
pharma/biopharma processes
pharmaceutical
solid formulation

application(s)

liquid formulation
ophthalmics
parenterals
pharma/biopharma processes
pharmaceutical
semi-solid formulation
solid formulation

application(s)

liquid formulation
ophthalmics
pharmaceutical
semi-solid formulation
solid formulation

application(s)

pharmaceutical (small molecule)

product line

EMPROVE® API

product line

EMPROVE® EXPERT

product line

EMPROVE® ESSENTIAL

product line

-

agency

BP, Ph. Eur., JP, USP

agency

BP, ChP, JP, Ph. Eur., USP, suitable for SM 4500 - NH3

agency

BP, JP, Ph. Eur., USP

agency

traceable to USP 1613859

bulk density

600 kg/m3

bulk density

-

bulk density

-

bulk density

-

pH

7.5-9.0 (25 °C, 50 g/L in H2O)

pH

7.5-9.0 (25 °C, 50 g/L in H2O)

pH

7.5-9.0 (25 °C, 50 g/L in H2O)

pH

-

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Stay compliant with GMP using the Emprove® Program

Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.

Download Dossiers

Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.

Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite

Not finding what you are looking for? Visit the Emprove® Program Help page.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Strategies for the Development of Safe and Effective Pediatric Formulations

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Related Content

Pediatric Formulations

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

APIs Tailored to Your Needs.

Global Trade Item Number

SKUGTIN
106666902904027269575038
106666100004027269670535